A common gastrointestinal cancer drug that crosses the blood-brain barrier showed promise in patients with aggressive high-grade gliomas. For avapritinib to be effective against HGGs, it would need to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results